logo

Aadi Bioscience, Inc. (AADI)



Trade AADI now with
  Date
  Headline
10/12/2022 8:08:41 AM Mirati, Aadi To Evaluate Adagrasib - Nab-sirolimus Combination In Advanced NSCLC And Other Solid Tumors
8/10/2022 8:03:18 AM Aadi Bioscience, Inc. Q2 Net Loss/shr $0.87 Vs. Loss/shr $0.60 Last Year
9/20/2021 8:35:26 AM Aadi Bioscience Appoints Brendan Delaney As COO